<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02417584</url>
  </required_header>
  <id_info>
    <org_study_id>PAPBP-01</org_study_id>
    <nct_id>NCT02417584</nct_id>
  </id_info>
  <brief_title>Efficacy of PAP Therapy on Blood Pressure</brief_title>
  <official_title>The Role of Compliance With Positive Airway Pressure Use on Blood Pressure in Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Crete</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Crete</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to determine the long term effects of compliance with positive&#xD;
      airway pressure therapy on blood pressure in both hypertensive and normotensive patients with&#xD;
      obstructive sleep apnoea hypopnoea syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scientific data about the causal role of obstructive sleep apnoea hypopnoea syndrome (OSAHS)&#xD;
      in the development of systemic hypertension and the effects of positive airway pressure (PAP)&#xD;
      treatment on blood pressure (BP) control are continuously increasing; however they are&#xD;
      controversial. We aimed to determine the long term effects of compliance with PAP therapy on&#xD;
      BP in both hypertensive and normotensive patients with OSAHS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>drop in blood pressure</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1168</enrollment>
  <condition>Obstructive Sleep Apnoea</condition>
  <arm_group>
    <arm_group_label>positive airway pressure (PAP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with positive airway pressure (PAP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>positive airway pressure (PAP)</intervention_name>
    <description>Positive Airway Pressure (PAP) is a non-invasive machine providing air pressure f to prevent the collapse of the oropharyngeal walls and the obstruction of airflow during sleep, which occurs in obstructive sleep apnea hypopnea syndrome.</description>
    <arm_group_label>positive airway pressure (PAP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  newly diagnosed OSAHS by polysomnography according to standard criteria&#xD;
&#xD;
          -  no history of previous PAP therapy&#xD;
&#xD;
          -  normotensive and hypertensive patients&#xD;
&#xD;
          -  an above-elementary school education.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal to participate&#xD;
&#xD;
          -  refusal of PAP therapy&#xD;
&#xD;
          -  secondary hypertension&#xD;
&#xD;
          -  central sleep apnea syndromes&#xD;
&#xD;
          -  obesity hypoventilation syndrome&#xD;
&#xD;
          -  restrictive ventilator syndromes&#xD;
&#xD;
          -  history of established cardiovascular disease&#xD;
&#xD;
          -  severe congestive heart failure&#xD;
&#xD;
          -  a history of life-threatening arrhythmias&#xD;
&#xD;
          -  severe cardiomyopathy&#xD;
&#xD;
          -  significant chronic kidney disease&#xD;
&#xD;
          -  long-term oxygen therapy&#xD;
&#xD;
          -  family or personal history of mental illness&#xD;
&#xD;
          -  drug or alcohol abuse&#xD;
&#xD;
          -  severe cognitive impairment&#xD;
&#xD;
          -  concurrent oncological diseases&#xD;
&#xD;
          -  need for chronic use of medication that may affect BP levels&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  history of narcolepsy or restless leg syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophia E Schiza, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Crete</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sleep Disorders Center, Department of Thoracic Medicine, University of Crete,</name>
      <address>
        <city>Heraklion</city>
        <zip>71110</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>April 11, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>April 14, 2015</last_update_submitted>
  <last_update_submitted_qc>April 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Crete</investigator_affiliation>
    <investigator_full_name>Izolde Bouloukaki</investigator_full_name>
    <investigator_title>MD, PhD, Consultant at NHS</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

